Jubilant Pharmova (BOM:530019) 3-Year Revenue Growth Rate : 2.10% (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Jubilant Pharmova 3-Year Revenue Growth Rate?

Jubilant Pharmova's Revenue per Share for the three months ended in Dec. 2023 was ₹104.70.

During the past 12 months, Jubilant Pharmova's average Revenue per Share Growth Rate was 7.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 2.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was -6.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Jubilant Pharmova was 29.00% per year. The lowest was -13.00% per year. And the median was 10.90% per year.

Competitive Comparison of Jubilant Pharmova's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Jubilant Pharmova's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jubilant Pharmova's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jubilant Pharmova's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Jubilant Pharmova's 3-Year Revenue Growth Rate falls into.

Jubilant Pharmova 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Jubilant Pharmova (BOM:530019) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Jubilant Pharmova 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Jubilant Pharmova's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Jubilant Pharmova (BOM:530019) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jubilant Pharmova Ltd (BOM:530019) » Definitions » 3-Year Revenue Growth Rate

Traded in Other Exchanges

JUBLPHARMA:India

Address

1A, Sector 16A, Noida, UP, IND, 201 301

Website

https://www.jubilantpharmova.com

Jubilant Pharmova Ltd is an integrated global pharmaceutical company. The company's segment includes Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment. Geographically, it derives a majority of its revenue from Americas and Europe.

Jubilant Pharmova (BOM:530019) Headlines

No Headlines